Ehrlich Karlheinz, Sicking Christa, Respondek Michael, Peskar Brigitta M
Department of Experimental Clinical Medicine, Ruhr University of Bochum, Bochum, Germany.
J Pharmacol Exp Ther. 2004 Jan;308(1):277-83. doi: 10.1124/jpet.103.057752. Epub 2003 Oct 20.
The cyclooxygenase (COX)-2 inhibitors 5,5-dimethyl-3-(3-fluorophenyl)-4-(4-methylsulfonyl)phenyl-2(5II)-furanone (DFU) (0.02-2 mg/kg) and N-[2-(cyclohexyloxy)-4-nitrofenyl]-methanesulfonamide (NS-398) (0.01-1 mg/kg), the COX-1 inhibitor 5-(4-chlorophenyl)-1-(4-methoxyphenyl)-3-trifluoromethylpyrazole (SC-560) (0.05-5 mg/kg), and dexamethasone (1 mg/kg) were studied in rats challenged with intragastric acid (300 mM HCl). All compounds induced severe gastric damage when rats were treated concurrently with the inhibitor of constitutive and inducible nitric-oxide (NO) synthase N(G)-monomethyl-L-arginine methyl ester (L-NAME) (3 or 40 mg/kg). DFU and NS-398 caused significantly less damage in rats receiving the selective inhibitor of inducible NO synthase N-(3-(aminomethyl)benzyl)acetamidine (1400W) (0.3 mg/kg). The COX-1 inhibitor SC-560 induced moderate damage in the acid-challenged stomach even without suppression of NO, but damage was aggravated by L-NAME. The COX-3 inhibitor phenacetin (400 mg/kg) did not injure the gastric mucosa despite suppression of NO. Furthermore, DFU, NS-398, SC-560, and dexamethasone caused severe injury in the acid-challenged stomach of rats pretreated with capsaicin to ablate afferent neurons. The mucosal damage induced by the COX-1 inhibitor, the COX-2 inhibitors, and dexamethasone in L-NAME- or capsaicin-treated rats was reversed by coadministration of 16,16-dimethyl-prostaglandin E2 (2 x 8 ng/kg). Gross mucosal damage was paralleled by histology. Our results support the concept that endogenous NO, prostaglandins, and afferent neurons act in concert in the regulation of gastric mucosal integrity. The prostaglandins necessary for mucosal defense in the face of NO suppression, and afferent nerve ablation can be derived either from COX-1 or COX-2. The data do not propose a protective role for a phenacetin-sensitive COX-3. Our findings suggest that not only COX-1 but also COX-2 has important functions in the maintenance of gastric integrity.
在经胃内给予酸(300 mM盐酸)刺激的大鼠中,研究了环氧化酶(COX)-2抑制剂5,5-二甲基-3-(3-氟苯基)-4-(4-甲磺酰基)苯基-2(5II)-呋喃酮(DFU)(0.02 - 2 mg/kg)和N-[2-(环己氧基)-4-硝基苯基]-甲磺酰胺(NS-398)(0.01 - 1 mg/kg)、COX-1抑制剂5-(4-氯苯基)-1-(4-甲氧基苯基)-3-三氟甲基吡唑(SC-560)(0.05 - 5 mg/kg)以及地塞米松(1 mg/kg)。当大鼠同时接受组成型和诱导型一氧化氮(NO)合酶抑制剂N(G)-单甲基-L-精氨酸甲酯(L-NAME)(3或40 mg/kg)治疗时,所有化合物均诱导严重的胃损伤。DFU和NS-398在接受诱导型NO合酶选择性抑制剂N-(3-(氨甲基)苄基)乙脒(1400W)(0.3 mg/kg)的大鼠中引起的损伤明显较少。COX-1抑制剂SC-560即使在不抑制NO的情况下,在酸刺激的胃中也诱导中度损伤,但L-NAME会加重损伤。COX-3抑制剂非那西丁(400 mg/kg)尽管抑制了NO,但并未损伤胃黏膜。此外,DFU、NS-398、SC-560和地塞米松在经辣椒素预处理以消除传入神经元的大鼠的酸刺激胃中引起严重损伤。COX-1抑制剂、COX-2抑制剂和地塞米松在L-NAME或辣椒素处理的大鼠中诱导的黏膜损伤,通过共同给予16,16-二甲基前列腺素E2(2×8 ng/kg)得以逆转。大体黏膜损伤与组织学表现一致。我们的结果支持内源性NO、前列腺素和传入神经元在调节胃黏膜完整性中协同作用的概念。面对NO抑制时黏膜防御所需的前列腺素以及传入神经消融可源自COX-1或COX-2。数据未表明非那西丁敏感的COX-3具有保护作用。我们的发现表明,不仅COX-1而且COX-2在维持胃完整性方面都具有重要功能。